Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-030182
Filing Date
2021-07-27
Accepted
2021-07-27 20:07:59
Documents
2
Period of Report
2021-07-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1653
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3100
  Complete submission text file 0000899243-21-030182.txt   6166
Mailing Address C/O FOUNDATION MEDICINE, INC. ONE KENDALL SQUARE, SUITE B3501 CAMBRIDGE MA 02139
Business Address
Kafka Steven J. (Reporting) CIK: 0001585005 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40676 | Film No.: 211119422

Mailing Address 345 PARK AVENUE SOUTH 12TH FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 12TH FLOOR NEW YORK NY 10010 (212) 551-1600
DA32 Life Science Tech Acquisition Corp. (Issuer) CIK: 0001863294 (see all company filings)

EIN.: 863352988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks